Richard Peters Net Worth & Insider Trades

Richard Peters - President and CEO, Yumanity Therapeutics, Inc

As of December 6, 2022

What is Richard Peters's Net Worth?

The current estimated net worth of Yumanity Therapeutics, Inc's President and CEO, Richard Peters, is estimated to be about $197.92K . Richard Peters owns about 90,028 units of Yumanity Therapeutics, Inc common stock. In the last 2 years at Yumanity Therapeutics, Inc, Richard Peters has sold an estimated value of $109.05K worth.

What is Richard Peters's Past Insider Trading?

Richard Peters's largest sale order was 10,715 units , worth over $19.77K on March 30, 2022. In total, Richard Peters has made about 8 transactions over 2 years of their time at Yumanity Therapeutics, Inc. Richard Peters usually trades in December, with the busiest year in 2022. The most recent transaction was a sale order of 10,890 units , worth over $18.42K on December 6, 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Richard Peters

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Richard Peters's' Mailing Address?

  • Mailing address is Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 MA

What are Yumanity Therapeutics, Inc's Past Insider Trades?

Yumanity Therapeutics, Inc's most recent insider trade came on December 6, 2022 by Richard Peters who sold 10,890 units worth $18.42K . In the last 11 months, insiders at Yumanity Therapeutics, Inc have sold an estimated value of $135.61K and bought an estimated value of $99.98K worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Richard Peters, President and CEO,  Marie Epstein, Principal Accounting Officer,  and Devin W. Smith, SVP and General Counsel .

YUMANITY THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...